Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Germany

 

Doctors queuing up to sell

After years of umming and ahhing, German doctors who own outpatient practices in areas like dentistry, imaging and ophthalmology are keen to sell. And deals continue to happen in spite of COVID.

Statutory insurers protect their hospitals, private pay markets look bleak

The post-COVID-19 financial outlook for private hospitals in Western Europe is becoming clearer. Those in statutory insurance-funded markets are likely to be protected by the public payor while private insurers look unlikely to shoulder the burden. And reimbursement for any COVID-19 care will barely make up the difference. 

Revenue halves for lab groups

HBI understands that lab groups across Europe are seeing revenue drops of 50% despite having extensive participation in COVID-19 testing. 

Tussle at Rhoen as shares soar above Asklepios’ offer

The management and supervisory boards of German hospital operator Rhoen Klinikum have recommended shareholders accept competitor Asklepios' takeover offer of €18.00 per share. But 25% shareholder B. Braun is proving troublesome and with Rhoen's share price now at €18.64, the saga seems far from over. 

COVID-19 may force re-think of German hospital ‘rationalisation’

Germany's arguably excessive hospital capacity, much of it in small regional hospitals, has proven an invaluable asset during coronavirus. A senior hospital executive tells us this may change policy conversations of the last 2-3 years around the need to trim the sector down, though paradoxically the crisis may also send the sector further into deficit.

European dental markets “could take years to recover from COVID”

As HBI Intelligence reviews the impact of COVID-19, HBI has been talking to operators and analysts. One EU-based operator says many markets across Europe will struggle to recover once the COVID-19 crisis has passed. Here is his view of where will be worst hit - and where we may see a surprising rebound.

Find Us